#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrodystrophy Solitary fibrous tumour Multiple system atrophy Rhabdomyosarcoma recurrent Proteus syndrome Cushing's syndrome Shprintzen-Goldberg syndrome Congenital myopathy Severe myoclonic epilepsy of infancy Congenital nephrogenic diabetes insipidus Glomerulonephritis Cutaneous calcification Lung adenocarcinoma Pituitary-dependent Cushing's syndrome Drug eruption More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Metachromatic leukodystrophy – Trials in Disease Uterine leiomyosarcoma – Diagnostics Usher’s syndrome Focal segmental glomerulosclerosis – Life with Disease Gastrointestinal stromal tumour Synovial sarcoma – Trials in Disease Sjogren’s syndrome – Trials in Disease Haemophilia B without inhibitors Glycogen storage disease type II – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cloxacillin Zimberelimab SAR444336 BW-20805 Sapropterin Dihydrochloride Cinchocaine Hydrochloride Lumateperone Dexamethasone Isonicotinate Vibostolimab Rbd1016 Abc-31-116 Esketamine Hydrochloride Bempikibart Triamcinolone Acetonide Wve-006 Azd8421 Talazoparib Paclitaxel Obaluronate Metformin Hydrochloride 177Lu-Rhpsma-10.1 More therapies…

    Learn about Your Condition

    Oesophageal cancer metastatic Short-bowel syndrome Vesicoureteric reflux Supraventricular tachycardia Schizoaffective disorder Exfoliation glaucoma Hyperhidrosis Incontinence B-cell type acute leukaemia Acquired haemophilia Triple positive breast cancer Neurotrophic keratopathy Axial spondyloarthritis Follicular lymphoma stage III Lymphocytic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac amyloidosis

  • A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Italy

  • Long-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary neuropathic amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Single Guide Rna Targeting The Human Ttr Gene
    • Ziclumeran
    France Sweden

  • Study on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Dobutamine
    • Sodium Chloride
    Denmark

  • Study on the Impact of Dapagliflozin on Quality of Life and Exercise Capacity in Patients with Transthyretin Cardiac Amyloidosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study on the Effects of Valsartan and Sacubitril for Patients with Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Spain
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!